当前位置：
X-MOL 学术
›
Nat. Rev. Drug. Disc.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Targeting the NLRP3 inflammasome in inflammatory diseases
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2018-08-17 , DOI: 10.1038/nrd.2018.149 Matthew S. J. Mangan , Edward J. Olhava , William R. Roush , H. Martin Seidel , Gary D. Glick , Eicke Latz
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2018-08-17 , DOI: 10.1038/nrd.2018.149 Matthew S. J. Mangan , Edward J. Olhava , William R. Roush , H. Martin Seidel , Gary D. Glick , Eicke Latz
Targeting the NLRP3 inflammasome in inflammatory diseases
中文翻译：
针对炎性疾病的NLRP3炎性体
针对炎性疾病的NLRP3炎性体
更新日期：2018-08-17
Targeting the NLRP3 inflammasome in inflammatory diseases, Published online: 17 August 2018; doi:10.1038/nrd.2018.149
Targeting the NLRP3 inflammasome in inflammatory diseases中文翻译：
针对炎性疾病的NLRP3炎性体
针对炎性疾病的NLRP3炎性体
针对NLRP3炎性疾病的炎症性疾病，在线发布于：2018年8月17日; doi：10.1038 / nrd.2018.149
针对炎性疾病的NLRP3炎性体
京公网安备 11010802027423号